Menu

Source Legend
  • Human-provided

    Entered or confirmed by an authorized person.

  • Google

    Imported Google information.

  • Trial-derived

    Calculated or extracted directly from associated trial records.

  • AI-inferred

    A capability inferred from trial history.

  • AI-extracted

    An explicit statement extracted from an official source.

  • Public registry

    Information from a public registry.

  • Site record

    Information held in the site record.

Source: Site record. Velocity Clinical Research-Raleigh, North Carolina

Verified

Basic Information

Site Overview

Source: Human-provided.

Velocity's Neurology research site in Raleigh partners with Raleigh Neurology Associates, P.A., to conduct clinical trials related to disorders of the nervous system. Raleigh Neurology began conducting clinical trials in 1996 and later partnered with Meridian Clinical Research before being acquired by Velocity in 2022. Through the partnership with Raleigh Neurology, the site is easily accessible to thousands of patients in the Research Triangle, including those established with the practice. All trials conducted at the site are performed in accordance with ICH and FDA guidelines, and in compliance with GCP. Our Raleigh team is committed to being a resource for study participants, to providing the highest quality of patient care with compassion and kindness, and to advancing medicine through research.

Source: Trial-derived.
3Total Trials
Source: Trial-derived.
2Recruiting Trials
Source: Trial-derived.
2Active Trials
Source: Trial-derived.
0Completed Trials
Source: Trial-derived.
4Unique Conditions
Source: Trial-derived.
3Unique Sponsors

Affiliations

Conditions

Source: Trial-derived. Alzheimer Disease (1)Source: Trial-derived. Dementia (1)Source: Trial-derived. Multiple Sclerosis (MS) Primary Progressive (1)Source: Trial-derived. Myasthenia Gravis (1)

Sponsors

Source: Trial-derived. Janssen Research & Development, LLC (1)Source: Trial-derived. Merck Sharp & Dohme LLC (1)Source: Trial-derived. Zenas BioPharma (USA), LLC (1)